Study of Maggot Therapy in Diabetic Foot Ulcers (MDT)

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Forough Pouryazdanpanah Kermani, Kerman Medical University
ClinicalTrials.gov Identifier:
NCT01681160
First received: September 4, 2012
Last updated: September 7, 2012
Last verified: September 2012

September 4, 2012
September 7, 2012
January 2009
December 2009   (final data collection date for primary outcome measure)
change from baseline in BATES-JENSEN WOUND ASSESSMENT score at 3days and change from baseline in BATES-JENSEN WOUND ASSESSMENT score at 6 days [ Time Frame: 2 years ] [ Designated as safety issue: No ]
Same as current
Complete list of historical versions of study NCT01681160 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Study of Maggot Therapy in Diabetic Foot Ulcers
Maggot Therapy in Diabetic Foot Ulcers

This study was a Kind of clinical trial with equal randomization, that have been done from January 2009 to June 2011 in the AFZALIPOOR hospital endocrine ward in Kerman-Iran on 128 diabetic patient who had foot wounds.Replacement of conventional therapy by new methodes is one of the more important aims for health professional specially for nurses.One of this new treatment is maggot therapy.

Not Provided
Interventional
Not Provided
Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Single Group Assignment
Masking: Single Blind (Outcomes Assessor)
Primary Purpose: Treatment
DIABETIC FOOT ULCERS
  • Other: procedure:maggot therapy
    each times in maggot therapy continued for three days.wound assessment was done before and after any intervention
    Other Name: larval therapy
  • Other: conventional therapy
    patients receive ordinary treatment for diabetic foot
    Other Name: mechanical debridement
Experimental: MAGGOT THERAPY & conventional therapy T
Maggot therapy,ADMINISTERED TWO TIMES AS A NEW METHODS OF DRESSING in experimental group.conventional therapy ,administered two times in control group
Interventions:
  • Other: procedure:maggot therapy
  • Other: conventional therapy
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
128
June 2011
December 2009   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • Have a chronic illness more than 7 weeks.
  • The age of the patients between 40- 90 years old.
  • Not having capillary disease (Blockage of artery, Rinold).
  • Not user of anticoagulants and corticosteroids drugs.
  • Patients without history of allergy to drugs and foods.
  • Having diabetic type 2

Exclusion Criteria:

  • patients who refer to critical clinical care unit
  • patients who have amputation
Both
40 Years to 90 Years
No
Contact information is only displayed when the study is recruiting subjects
Not Provided
 
NCT01681160
86/116
Yes
Forough Pouryazdanpanah Kermani, Kerman Medical University
Kerman Medical University
Not Provided
Not Provided
Kerman Medical University
September 2012

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP